
PMC:7247521 / 28024-28279
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
404 | 120-124 | Gene | denotes | hERG | Gene:2078 |
405 | 138-142 | Gene | denotes | hERG | Gene:2078 |
406 | 162-165 | Species | denotes | rat | Tax:10116 |
407 | 53-61 | Disease | denotes | toxicity | MESH:D064420 |
408 | 86-94 | Disease | denotes | toxicity | MESH:D064420 |
409 | 172-180 | Disease | denotes | toxicity | MESH:D064420 |
410 | 189-203 | Disease | denotes | hepatotoxicity | MESH:D056486 |
411 | 205-223 | Disease | denotes | skin sensitisation | MESH:D012871 |
412 | 236-244 | Disease | denotes | toxicity | MESH:D064420 |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T361 | 12-21 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
T362 | 81-85 | CHEBI:34018;CHEBI:34018 | denotes | AMES |
T363 | 120-124 | PR:P11308 | denotes | hERG |
T364 | 127-136 | CHEBI:35222;CHEBI:35222 | denotes | inhibitor |
T365 | 138-142 | PR:P11308 | denotes | hERG |
T366 | 146-155 | CHEBI:35222;CHEBI:35222 | denotes | inhibitor |
T367 | 157-161 | UBERON:0000165 | denotes | oral |
T368 | 162-165 | NCBITaxon:10114 | denotes | rat |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T94 | 205-209 | Body_part | denotes | skin | http://purl.org/sig/ont/fma/fma7163 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T33 | 205-209 | Body_part | denotes | skin | http://purl.obolibrary.org/obo/UBERON_0000014 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T236 | 205-209 | http://purl.obolibrary.org/obo/UBERON_0000014 | denotes | skin |
T237 | 205-209 | http://purl.obolibrary.org/obo/UBERON_0001003 | denotes | skin |
T238 | 205-209 | http://purl.obolibrary.org/obo/UBERON_0002097 | denotes | skin |
T239 | 205-209 | http://purl.obolibrary.org/obo/UBERON_0002199 | denotes | skin |
T240 | 205-209 | http://www.ebi.ac.uk/efo/EFO_0000962 | denotes | skin |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T171 | 127-136 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
T172 | 143-145 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T173 | 146-155 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T200 | 0-255 | Sentence | denotes | Finally, 14 compounds did not present any particular toxicity problems including AMES toxicity, maximum tolerated dose, hERG I inhibitor, hERG II inhibitor, oral rat acute toxicity (LD50), hepatotoxicity, skin sensitisation, and minnow toxicity (Fig. 7B). |